You are here

bladder cancer

ESMO: Astellas, Seattle Genetics' Keytruda combo shrinks 71% of bladder cancers

ESMO: Astellas, Seattle Genetics' Keytruda combo shrinks 71% of bladder cancers

Fierce Biotech

Seattle Genetics

enfortumab vedotin

urothelial cancer

Flag link:

Oncologists listen when the FDA speaks, even after a drug hits the market

Oncologists listen when the FDA speaks, even after a drug hits the market

Endpoints

Flag link:

Sesen Bio reports data update from phase 3 trial for high-risk non-muscle invasive bladder cancer

Sesen Bio reports data update from phase 3 trial for high-risk non-muscle invasive bladder cancer

Pharmaceutical Business Review

clinical trials

Flag link:

Roche says test showed Tecentriq helped vs bladder cancer

Roche says test showed Tecentriq helped vs bladder cancer

Reuters

Flag link:

Did cancer clinical trials stay on track at ASCO 2019?

Did cancer clinical trials stay on track at ASCO 2019?

Pharmaforum

clinical trials

prostate cancer

pancreatic cancer

Flag link:

Inovio axes staffers, cancer program to 'sharpen focus,' save cash

Inovio axes staffers, cancer program to 'sharpen focus,' save cash

Fierce Biotech

Flag link:

Cold virus strain could be used as therapy for bladder cancer – study

Cold virus strain could be used as therapy for bladder cancer – study

Pharmaforum

coxsackievirus virus

Flag link:

Roche throws in the towel on Tecentriq bladder, myeloma trials

Roche throws in the towel on Tecentriq bladder, myeloma trials

Fierce Pharma

Multiple Myeloma

clinical trials

Flag link:

Clovis down after discontinuing rucaparib bladder cancer trial

Clovis down after discontinuing rucaparib bladder cancer trial

BioCentury

Clovis Oncology

Flag link:

J&J's Balversa gets accelerated approval for bladder cancer

J&J's Balversa gets accelerated approval for bladder cancer

BioCentury

Flag link:

NanOlogy enrolls first patient in phase 1/2 clinical trial of NanoDoce to treat bladder cancer

NanOlogy enrolls first patient in phase 1/2 clinical trial of NanoDoce to treat bladder cancer

Pharmaceutical Business Review

clinical trials

Flag link:

Key bladder cancer data pave way for Seattle Genetics to submit marketing application for armed antibody

Key bladder cancer data pave way for Seattle Genetics to submit marketing application for armed antibody

Endpoints

Seattle Genetics

enfortumab vedotin

Flag link:

miR Scientific Presents Urine Based Test for Detecting Prostate and Bladder Cancer

miR Scientific Presents Urine Based Test for Detecting Prostate and Bladder Cancer

CP Wire

prostate cancer

Flag link:

miR Scientific Presents Urine Based Test for Detecting Prostate and Bladder Cancer

prostate cancer

Flag link:

Merck limits orders for bladder cancer drug as demand outstrips supply

Merck limits orders for bladder cancer drug as demand outstrips supply

Fierce Pharma

Flag link:

Nektar, Bristol combo drug shows signs of tumor reduction in bladder cancer patients

Nektar, Bristol combo drug shows signs of tumor reduction in bladder cancer patients

Yahoo/Reuters

Bristol-Myers Squibb

Flag link:

Bladder cancer readout sees Nektar shares hit

Bladder cancer readout sees Nektar shares hit

Fierce Biotech

Nektar Therapeutics

Bristol-Myers Squibb

Flag link:

Theralase AnnouncesTwo Patients Free of Bladder Cancer After Single Treatment in Ph Ib Study

Theralase AnnouncesTwo Patients Free of Bladder Cancer After Single Treatment in Ph Ib Study

CP Wire

Flag link:

Theralase AnnouncesTwo Patients Free of Bladder Cancer After Single Treatment in Ph Ib Study

Flag link:

FDA limits first-line bladder cancer labels for Keytruda, Tecentriq

FDA limits first-line bladder cancer labels for Keytruda, Tecentriq

Biopharma Dive

Flag link:

Pages